Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Atrium Acquires Douglas Laboratories Canada - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Atrium Acquires Douglas Laboratories Canada

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Atrium Acquires Douglas Laboratories Canada
Atrium Biotechnologies Inc., Quebec, Canada, has acquired the assets of London, Ontario, Canada-based Douglas Laboratories Canada (DL Canada). DL Canada has been marketing Douglas Laboratories products in Canada since 2000 and has current annual revenues of approximately $5 million. The acquisition provides Atrium with a platform to develop the Canadian healthcare professional market, not only for the Douglas Laboratories brand, but also for the Pure Encapsulations brand, which is not currently being sold in Canada. Atrium will also be able to benefit from the expertise and support of DL Canada’s current management and staff who are staying on to ensure the successful integration and to sustain its growth.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters